MEDICAL DEICES VENTURE: Medical Devices Venture, an accelerator of new medical technologies, announces the entry of an investor into the capital of Poladerma – 01.06.2022 at 17:45

Igni, 1

uh

June 2022 – Medical Devices Venture (ISIN: FR0014006PT9 – mnemonic: MLMDV), an investment and acceleration platform at MedTech, announces the entry of a new investor into the capital of Poladerme.

The equity stake in Poladerme (approximately 9%) of the Wongs Group through its subsidiary Top Plenty Ltd is part of Poladerme’s business development strategy to prepare a distribution network for Poladerme products. Wong Group is a major Hong Kong player in the field of new technologies, real estate development and strategic investments. Wongs Group invests in various sectors, including new technologies and healthcare. He found in Poladerme an innovative dermatological solution tailored to the needs of the market.

Loïc Poirier, President of Poladerme, states: “We are proud to have the Wongs Group as a shareholder of Poladerme. This group is developing many activities in Asia and we intend to contract WONGS to distribute Poladerme products in this region, with a focus on dermatology and cosmetics activities. This entry into the capital of Poladerme is also a guarantee of the relevance of the project and will accelerate development outside of Europe once we enter the marketing phase.”


POLADERME: artificial intelligence at the service of dermatology and cosmetology

Poladerm

whose ambition to be a leader in spectropolarimetry combined with artificial intelligence and machine learning applied to dermatology is the result of over 10 years of research in spectropolarimetry, treatment and image analysis by professors Jihad Zallat and Christian Heinrich.

Poladerme, developed by Conectus, Strasbourg SATT, develops an innovative, fast and non-invasive diagnostic solution based on an optical system and artificial intelligence algorithms for deep tissue analysis and skin health assessment. This innovative tool will use what is to be the world’s only database of medical polarimetric images, thereby improving analysis capabilities with each new image.

contacts

Loic Poirier

[email protected]

About the enterprise for the production of medical devices

A subsidiary of ARCHOS, Medical Devices Venture, is a holding company that develops a portfolio of investments in Med Tech startups. The aim is to combine the experience of researchers in hospitals and universities with the industrialization, certification and marketing strength of the group.

More information: www.medicaldevicesventure.com


About Wong’s International Holdings Limited

Wong’s International Holdings Limited (WIHL), founded in 1962, is a well established Hong Kong listed company. WIHL’s scope of work includes; a) Electronics Manufacturing Services (EMS) provided by a subgroup consisting of Wong’s Electronics Holdings Company Limited (WEHC) and several WEHC subsidiaries, including Wong’s Electronics Company Limited (WEC), Welco Wong’s Technology (Shenzhen) Limited, wellop. Technology (Shenzhen) Limited, Welco Technology (Suzhou) Limited, Welco Technology Vietnam Company Limited; (b) development and marketing of original products and solutions (ODM); (c) development by Wong’s Development Limited; (d) strategic investments in new technologies and healthcare.

Based in Hong Kong, WIHL has manufacturing facilities at An Phat Industrial Park in Hai Duong, Vietnam, Shajing, Shenzhen and Suzhou, Jiangsu Province, and an R&D center in Luohu, Shenzhen. It also has global sales and marketing offices in Hong Kong, Shenzhen, Beijing, Shanghai, Tokyo, London, Santa Clara and Vienna.

WIHL currently has over 3,500 employees.


This post has the service “🔒 Actusnews SECURITY MASTER”.


– MASTER SECURITY KEY:

xm9xkpaaYZeanWyalZVsapZrmW5llpGaZmOWmJNuaseVnG1gyWiVaMrGZnBlnWdv

– To check this key:

https://www.security-master-key.com.



Unregulated Information:


Full and original press release in PDF format:

https://www.actusnews.com/news/74829-medical-devices-venture_-entree-d_un-nouvel-investor-au-capital-de-poladerme_juin-2022.pdf

© Copyright Actusnews Wire

Receive the next company press releases for free by email by subscribing to www.actusnews.com

.